Wellness Check: Exercise
Higher cardiorespiratory fitness may be protective against breast cancer in postmenopausal women 1. In this prospective cohort study, higher cardiorespiratory ...
Tag: Breast Cancer
Dose-escalated simultaneous integrated boost radiotherapy may increase ipsilateral breast tumor relapse rates
1. 5-year ipsilateral breast tumor relapse rates for test group 1 were non-inferior to the control group. However, noninferiority was ...
ChatGPT accurately selects imaging modality for breast cancer screening and pain assessment
1. In this clinical decision support study, the performance of the Chat Generative Pre-training Transformer (ChatGPT) in recommending appropriate imaging ...
Trastuzumab deruxtecan superior to physician’s choice treatment in patients with metastatic HER2-positive breast cancer
1. Progression-free survival was greater in the trastuzumab group compared to standard care (17.8 months vs. 6.9 months). 2. Drug-related ...
The 2 Minute Medicine Podcast Episode 15
Welcome to the 2 Minute Medicine Podcast, summarizing the latest medical studies, curated and written by practicing physicians. On this ...
The Scan by 2 Minute Medicine®: Mammogram Recommendation Changes, COVID Called Off, Canadian Wildfires, and National Nurses Week
The Scan by 2 Minute Medicine® is a pop-culture medical newsletter and exclusive benefit for 2 Minute Medicine Plus subscribers. ...
Alternative Dose Regimens of Exemestane in Postmenopausal Women with Breast Cancer
1. Through the reduction in serum estradiol, there was noninferiority between the 3-times-weekly vs once-daily dosage among compliant participants (PP ...
Combination therapy with alisterib and fulvestrant may be clinically advantageous in the treatment of endocrine-resistant advanced breast cancer
1. Compared to alisertib alone, adding alisertib to fulvestrant did not increase objective tumour response rates to treatment nor progression-free survival. ...
Liver enzymes elevated at 6 months prior to breast cancer liver metastasis detection
1. For patients diagnosed with breast cancer liver metastases (BCLM), liver function tests were found to be elevated at 6 ...
#StudyGraphics: Adjuvant abemaciclib improves survival in patients with hormone receptor-positive early breast cancer
Click to read this study in The Lancet Oncology.
